SavedAdd your journal

Journals / Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2015 / Cilt: 26 - Sayı: 1

The Association Between Non-Alcholic Fatty Liver Disease With Carotid Intima Media Thickness

Nonalkolik Yağlı Karaciğer Hastalığı ve Karotis İntima Media Kalınlığı İlişkisi

Emre DURAKOĞLUGİL
Tugba DURAKOĞLUGİL
Osman Zikrullah ŞAHİN
Serap ŞAHİN BAYDUR
Teslime AYAZ
Abdulkadir KIRVAR
Pages
13–18
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Carotid artery intima media thickness was significantly higher among hepatosteatosis patients (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: The aim of the study was to evaluate carotid artery intima media thickness in patients with non-alcholic fatty liver disease and in healthy controls.
📊
Key Findings & Data:Methods: A total of 100 patients with hepatosteatosis as diagnosed by upper abdominal ultrasonography and 30 healthy subjects without hepatosteatosis who presented at the internal medicine clinic were enrolled in the study.
💡
Conclusion & Impact:Results: Carotid artery intima media thickness was significantly higher among hepatosteatosis patients (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background: The aim of the study was to evaluate carotid artery intima media thickness in patients with non-alcholic fatty liver disease and in healthy controls. Methods: A total of 100 patients with hepatosteatosis as diagnosed by upper abdominal ultrasonography and 30 healthy subjects without hepatosteatosis who presented at the internal medicine clinic were enrolled in the study. Carotid artery intima media thickness was measured in all study subjects by ultrasonography. Patient lipid profile, fasting serum basal insulin, fasting plasma glucose, homeostatic insulin resistance, C- reactive protein level, and liver function tests were completed and evaluated in all study subjects. Results: Carotid artery intima media thickness was significantly higher among hepatosteatosis patients (p

Özet

Amaç: Çalışmada non-alkolik yağlı karaciğer hastaları ve sağlıklı kontrollerin karotid arter intima-media kalınlığınıın karşılaştırılması amaçlanmıştır. Gereç ve Yöntem: Hastanemiz dahiliye polikliniğe başvuran ve üst abdomen ultrasonografisinde karaciğer yağlanması tespit edilen 100 hasta ve yağlanması olmayan 30 kişi kontrol grubu olarak alındı. Tüm bireylerin, karotis intima media kalınlıkları ultrasonografi ile ölçüldü. Lipid profilleri, açlık serum insülini, açlık kan şekeri, homeostasis model of assessment-insulin resistance, C-reaktif protein ve karaciğer fonksiyon testleri ileriye yönelik olarak karşılaştırılmıştır. Bulgular: Hastalarının karotis intima media kalınlıkları (sağ, sol ve ortalama değerleri için p

🔖

Cite This Article

DURAKOĞLUGİL, E., DURAKOĞLUGİL, T., ŞAHİN, O. Z., BAYDUR, S. Ş., AYAZ, T., KIRVAR, A. (2022). The Association Between Non-Alcholic Fatty Liver Disease With Carotid Intima Media Thickness. Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 26 - Sayı: 1, 13–18. https://ajindex.com/articles/571323

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001;21(1):3-16
  2. McCullough AJ. Update on nonalcoholic fatty liver disease. J Clin Gastroenterol 2002;34(3):255-62
  3. Sanyal AJ; American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002;123(5):1705-25
  4. Musso G, Cassader M, Rosina F, Gambino R. Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia 2012;55(4):885-904
  5. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006;43(2 Suppl 1):S99-S112
  6. Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2007;25(8):883-9
  7. Musso G, Gambino R, Bo S, Uberti B, Biroli G, Pagano G, Cassader M. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. Diabetes Care 2008;31(3):562-8
  8. Sookoian S, Burgueño AL, Castaño G, Pirola CJ. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with adult treatment panel III criteria in nonobese nondiabetic subjects: response to Musso et al. Diabetes Care 2008;31(5):e42; author reply e43
  9. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001;50(8):1844-50
  10. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288(21):2709-16
  11. Targher G, Bertolini L, Rodella S, Tessari R, Zenari L, Lippi G, et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care 2007;30(8):2119-21
  12. Haring R, Wallaschofski H, Nauck M, Dörr M, Baumeister SE, Völzke H. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels. Hepatology 2009;50(5):1403-11
  13. Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R, et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events